AG
Adrian Gervais
Institut des Maladies Génétiques Imagine
Research areas: Immunology and Microbiology · Immunology · interferon and immune responses · SARS-CoV-2 and COVID-19 Research · COVID-19 Clinical Research Studies
0000-0002-1083-5787
Employment
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (30)
- Type I IFN autoantibodies in three of seven Europeans with life-threatening Usutu virus infection Save
- Autoantibodies neutralizing type I interferons in COVID-19 patients from southern Brazil Save
- Autoantibodies neutralizing type I interferons in older twin pairs: Low concordance Save
- Autoantibodies neutralizing type I IFNs underlie ~5% of herpes simplex encephalitis in adults Save
- High Nasopharyngeal SARS-CoV-2 Load and Delayed Clearance in Hospitalized Patients With Blood Autoantibodies Neutralizing Type I Interferons Save
- Autoantibodies neutralizing type I interferons underlie a third of cases of Chikungunya virus encephalitis or myelitis Save
- Autoantibodies neutralizing type I interferons underlie a third of cases of Chikungunya virus encephalitis or myelitis Save
- Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohorts Save
- Autoantibodies neutralizing type I IFNs in a fatal case of H5N1 avian influenza Save
- Autoantibodies neutralizing type I IFNs in patients with fulminant herpes simplex virus hepatitis Save
- Auto-Abs against type I IFNs: Strong, common, and global determinants of severe arboviral diseases Save
- Inherited IL-18BP deficiency in two Egyptian siblings with fulminant viral hepatitis Save
- Prevalence and association of type I IFN autoantibodies with clinical outcomes in critically ill Brazilian COVID-19 patients Save
- Rapid Detection of Anti‐IFN‐α2 Autoantibodies Using a New Automated VIDAS Assay Prototype Save
- Auto-Abs neutralizing type I IFNs in patients with severe Powassan, Usutu, or Ross River virus disease Save
- Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases Save
- Autoantibodies neutralizing type I IFNs underlie severe tick-borne encephalitis in ∼10% of patients Save
- Autoantibodies to type I interferons : key factors in severe viral infections and emerging clinical applications Save
- Human autoantibodies neutralizing type I IFNs: From 1981 to 2023 Save
- Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children Save